Mori Shinobu, Satou Mayumi, Kanazawa Satoshi, Yoshizuka Naonobu, Hase Tadashi, Tokimitsu Ichiro, Takema Yoshinori, Nishizawa Yoshinori, Yada Toshihiko
Biological Science Laboratories, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-gun, Tochigi 321-3497, Japan.
Int J Biol Sci. 2009;5(4):311-8. doi: 10.7150/ijbs.5.311. Epub 2009 Apr 28.
We have found natural products exhibiting lipolysis-promoting activity in subcutaneous adipocytes, which are less sensitive to hormones than visceral adipocytes. The activities and a action mechanisms of a novel plant extract of Cirsium oligophyllum (CE) were investigated in isolated adipocytes from rat subcutaneous fat, and its fat-reducing effects by peroral administration and topical application were evaluated in vivo. CE-induced lipolysis was synergistically enhanced by caffeine, a phosphodiesterase inhibitor, and was reduced by propranolol, a beta adrenergic antagonist. The peroral administration of 10% CE solution to Wistar rats for 32 days reduced body weight gain, subcutaneous, and visceral fat weights by 6.6, 26.2, and 3.0%, respectively, as compared to the control group. By the topical application of 2% of this extract to rats for 7 days, weight of subcutaneous fat in the treated skin was reduced by 23.2%. This fat mass reduction was accompanied by the up-regulation of uncoupling protein 1 (UCP), a principal thermogenic mitochondrial molecule related to energy dissipating, in subcutaneous fat and UCP3 in skin except for the fat layer. These results indicate that CE promotes lipolysis via a mechanism involving the beta adrenergic receptor, and affects the body fat mass. This fat reduction may be partially due to UCP up-regulation in the skin including subcutaneous fat. This is the first report showing that repeated lipolysis promotion through CE administration may be beneficial for the systematic suppression of body fat accumulation or the control of fat distribution in obesity.
我们发现了一些天然产物,它们在皮下脂肪细胞中具有促进脂肪分解的活性,而皮下脂肪细胞对激素的敏感性低于内脏脂肪细胞。我们研究了少花蓟(Cirsium oligophyllum,CE)一种新型植物提取物在大鼠皮下脂肪分离脂肪细胞中的活性和作用机制,并在体内评估了其口服和局部应用的减脂效果。咖啡因(一种磷酸二酯酶抑制剂)可协同增强CE诱导的脂肪分解,而普萘洛尔(一种β肾上腺素能拮抗剂)则可降低该作用。与对照组相比,给Wistar大鼠口服10%的CE溶液32天,体重增加、皮下脂肪和内脏脂肪重量分别降低了6.6%、26.2%和3.0%。将该提取物2%局部应用于大鼠7天,处理皮肤处的皮下脂肪重量降低了23.2%。这种脂肪量的减少伴随着解偶联蛋白1(UCP)的上调,UCP是一种与能量消耗相关的主要产热线粒体分子,在皮下脂肪中以及除脂肪层外的皮肤中的UCP3也上调。这些结果表明,CE通过涉及β肾上腺素能受体的机制促进脂肪分解,并影响身体脂肪量。这种减脂可能部分归因于包括皮下脂肪在内的皮肤中UCP的上调。这是第一份报告表明,通过给予CE反复促进脂肪分解可能有利于系统性抑制身体脂肪堆积或控制肥胖中的脂肪分布。